tiprankstipranks
Trending News
More News >
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
US Market
Advertisement

Royalty Pharma (RPRX) Technical Analysis

Compare
1,281 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Royalty Pharma PLC’s (RPRX) Moving Averages Convergence Divergence (MACD) indicator is 0.11, suggesting Royalty Pharma PLC is a Sell.
Royalty Pharma PLC’s (RPRX) 20-Day exponential moving average is 36.08, while Royalty Pharma PLC’s (RPRX) share price is $37.01, making it a Buy.
Royalty Pharma PLC’s (RPRX) 50-Day exponential moving average is 35.94, while Royalty Pharma PLC’s (RPRX) share price is $37.01, making it a Buy.

Royalty Pharma (RPRX) Pivot Points

Oct 20, 2025, 05:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
35.41
35.64
35.99
36.22
36.57
36.80
37.15
Fibonacci
35.64
35.86
36.00
36.22
36.44
36.58
36.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Royalty Pharma (RPRX) Moving Averages

Oct 20, 2025, 05:43 AM
Period
Simple
Exponential
MA5
36.19Buy
36.41Buy
MA10
36.14Buy
36.21Buy
MA20
35.93Buy
36.08Buy
MA50
36.06Buy
35.94Buy
MA100
35.66Buy
35.22Buy
MA200
33.56Buy
32.94Buy
Royalty Pharma PLC’s (RPRX) 10-Day exponential moving average is 36.21, while Royalty Pharma PLC’s (RPRX) share price is $37.01, making it a Buy.
Royalty Pharma PLC’s (RPRX) 100-Day exponential moving average is 35.22, while Royalty Pharma PLC’s (RPRX) share price is $37.01, making it a Buy.
Royalty Pharma PLC’s (RPRX) stock price is $37.01 and Royalty Pharma PLC’s (RPRX) 50-day simple moving average is 36.06, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $37.01 and Royalty Pharma PLC’s (RPRX) 100-day simple moving average is 35.66, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $37.01 and Royalty Pharma PLC’s (RPRX) 200-day simple moving average is 33.56, creating a Buy signal.

Royalty Pharma (RPRX) Technical Indicators

Oct 20, 2025, 05:43 AM
Name
Value
Implied Action
RSI (14)
60.74
Neutral
STOCH (9,6)
82.82
Sell
STOCHRSI (14)
84.30
Sell
MACD (12,26)
0.11
Sell
ADX (14)
11.58
Buy
Williams %R
-5.53
Sell
CCI (14)
161.97
Sell
ATR (14)
0.71
-
Ultimate Oscillator
62.04
Neutral
ROC
4.99
Buy
Royalty Pharma PLC’s (RPRX) Relative Strength Index (RSI) is 60.74, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Trend Strength Indicator (ADX) is 11.58, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) Commodity Channel Index (CCI) is 161.97, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) Price Rate of Change (ROC) is 4.99, creating a Buy signal.

FAQ

Is RPRX a Buy, Hold, or Sell?
Based on RPRX’s technical indicators, RPRX is a Buy.
    What is RPRX’s RSI (14)?
    RPRX’s RSI (14) is 60.74, which suggests RPRX is a Neutral.
      What is RPRX’s MACD?
      RPRX’s MACD is 0.11, which suggests RPRX is a Sell.
        What is RPRX’s 5-day moving average?
        RPRX’s 5-day moving average is 36.19, which suggests RPRX is a Buy.
          What is RPRX’s 20-day moving average?
          RPRX 20-day moving average is 35.93, which suggests RPRX is a Buy.
            What is RPRX’s 50-day moving average?
            RPRX’s 50-day moving average is 36.06, which suggests RPRX is a Buy.
              What is RPRX’s 200-day moving average?
              RPRX’s 200-day moving average is 33.56, which suggests RPRX is a Buy.
                What is RPRX’s Williams % R (14)?
                RPRX’s Williams % R (14) is -5.53, which suggests RPRX is a Sell.
                  What is RPRX’s CCI (14)?
                  RPRX’s CCI (14) is 161.97, which suggests RPRX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis